Free Trial

Burning Rock Biotech (BNR) SEC Filings & 10K Form

Burning Rock Biotech logo
$6.58 +0.43 (+6.99%)
(As of 12/20/2024 05:15 PM ET)

Recent Burning Rock Biotech SEC Filings

DateFilerForm TypeView
12/04/2024
5:06 AM
Burning Rock Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/26/2024
7:24 AM
Burning Rock Biotech (Filer)
Form 20-F/A
11/14/2024
11:29 AM
Burning Rock Biotech (Subject)
Kynam Capital Management, LP (Filed by)
Form SC 13G/A
09/27/2024
8:15 AM
Burning Rock Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/20/2024
6:27 AM
Burning Rock Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/18/2024
12:59 PM
Burning Rock Biotech (Filer)
Form 424B3
09/06/2024
5:16 AM
Burning Rock Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/23/2024
5:06 AM
Burning Rock Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/19/2024
5:04 AM
Burning Rock Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/03/2024
5:08 AM
Burning Rock Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/29/2024
5:05 AM
Burning Rock Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/14/2024
5:06 AM
Burning Rock Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/29/2024
5:17 AM
Burning Rock Biotech (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
04/26/2024
7:30 AM
Burning Rock Biotech (Subject)
Form F-6 POS
04/26/2024
7:30 AM
Burning Rock Biotech (Subject)
Citibank,N.A./ADR (Filed by)
Citibank,N.A./ADR (Filed by)
Form F-6 POS
04/26/2024
5:06 AM
Burning Rock Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/28/2024
4:25 PM
Burning Rock Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/14/2024
11:45 AM
Burning Rock Biotech (Subject)
Kynam Capital Management, LP (Filed by)
Form SC 13G/A
02/13/2024
4:23 PM
Burning Rock Biotech (Subject)
LAV Biosciences Fund V, L.P. (Filed by)
Form SC 13G
02/09/2024
7:01 PM
Burning Rock Biotech (Subject)
GIC Private Ltd (Filed by)
Form SC 13G/A
01/10/2024
3:08 PM
Burning Rock Biotech (Subject)
Kynam Capital Management, LP (Filed by)
Form SC 13G
01/04/2024
5:01 AM
Burning Rock Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:BNR) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners